Citadel Advisors »

Eikon Therapeutics shares owned by Citadel Advisors

Quarter-by-quarter ownership of Eikon Therapeutics shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Eikon Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Eikon Therapeutics held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Eikon Therapeutics by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2026-03-31 $3.3M 310k 10.58

More positions owned by Citadel Advisors

State Str Spdr S&p 500 Etf T Tr Unit Call Option (SPY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
NVIDIA Corporation Call Option (NVDA)
Tesla Motors Call Option (TSLA)
Spdr Gold Tr Gold Shs Call Option (GLD)
Apple Call Option (AAPL)
Meta Platforms Cl A Call Option (META)
Microsoft Corporation Call Option (MSFT)
Amazon Call Option (AMZN)
Micron Technology Call Option (MU)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Netflix Call Option (NFLX)
Broadcom Call Option (AVGO)
Alphabet Cap Stk Cl C Call Option (GOOG)

View all positions for Citadel Advisors

Top funds holding Eikon Therapeutics

BlackRock
Foresite Capital Management IV
Merck & Co
Foresite Capital Management V
Capital World Investors
Alliancebernstein
Vanguard Capital Management
EcoR1 Capital
Baker Bros. Advisors
Soros Capital Management
StepStone
Canada Pension Plan Investment Board
Franklin Resources
Citadel Advisors
General Catalyst Group Management

View all funds holding Eikon Therapeutics